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Abstract
Background:  There  is  growing  evidence  that  gut  ﬂora  plays  a  role  in  the  development  of  Irri-
table Bowel  Syndrome  (IBS).  Abdominal  bloating  is  a  common  symptom  in  these  patients  and
the severity  of  this  symptom  could  be  related  to  the  variations  in  their  fermentative  proﬁles,
obtained  by  measuring  the  levels  of  breath  hydrogen  excretion  after  lactulose  ingestion.
Aims: Our  objective  was  to  determine  the  difference  in  abdominal  bloating  severity  between
IBS patients  with  high  vs  low  levels  of  breath  hydrogen  excretion  after  lactulose  administration.
Methods: Lactulose  breath  tests  were  carried  out  on  IBS  patients  in  our  institution  between
July 2009  and  August  2010.  Patients  were  requested  to  ﬁll  out  a  validated  questionnaire  to
assess the  severity  of  their  symptoms.  Abdominal  bloating  severity  score  was  compared  among
patients with  high  and  low  breath  hydrogen  levels.
Results: A total  of  234  patients  were  enrolled.  There  was  a  statistically  signiﬁcant  difference  in
the abdominal  bloating  severity  score  between  groups:  7.0  (5.7-8.0)  vs  6.5  (5.0-7.5),  p=0.001.
The comparison  among  IBS  patients  with  constipation  (IBS-C)  in  both  groups  also  showed  a
statistically  signiﬁcant  difference:  7.5  (6.0-8.5)  vs  5.8  (3.5-7.2),  p=0.0051.
Conclusions:  Those  patients  with  a  low  level  of  breath  hydrogen  excretion  after  lactulose  inges-
tion presented  with  signiﬁcantly  greater  abdominal  bloating  than  those  with  a  high  level  of
breath hydrogen  excretion.
© 2011  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
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Comparación  de  la  severidad  de  la  distensión  abdominal  entre  pacientes  con
síndrome  de  intestino  irritable,  con  bajo  y  alto  nivel  de  hidrógeno  espirado  en  la
prueba  de  aliento  con  lactulosa
Resumen
Introducción: Existen  cada  vez  más  evidencias  de  que  la  ﬂora  intestinal  juega  un  papel  en  el
desarrollo  del  síndrome  de  intestino  irritable  (SII).  La  sensación  de  distensión  abdominal  es  un
síntoma frecuente  en  estos  pacientes,  y  la  severidad  del  mismo  pudiera  estar  relacionada  con
las variaciones  en  el  perﬁl  fermentativo,  de  acuerdo  con  los  niveles  de  hidrógeno  espirado  luego
de la  ingesta  de  lactulosa.
Objetivos:  Determinar  la  diferencia  en  la  severidad  de  la  sensación  de  distensión  abdominal
entre pacientes  con  SII,  con  alto  vs  bajo  nivel  de  hidrógeno  espirado  luego  de  la  administración
de lactulosa.
Métodos:  Se  realizaron  pruebas  de  aliento  con  lactulosa  en  pacientes  con  SII  de  nuestra  institu-
ción, entre  julio  del  2009  y  agosto  del  2010.  A  todos  los  pacientes  se  les  solicitó  que  completaran
un cuestionario  validado,  para  determinar  la  severidad  de  sus  síntomas.  De  acuerdo  con  este,  se
comparó  la  severidad  de  la  distensión  abdominal  entre  pacientes  alto  y  bajo  nivel  de  hidrógeno
espirado.
Resultados: Un total  de  234  pacientes  fueron  incluidos.  Se  encontró  una  diferencia  estadísti-
camente signiﬁcativa  en  el  grado  de  severidad  de  la  distensión  abdominal  entre  los  grupos:  7,0
(5,7-8,0) vs  6,5  (5,0-7,5),  p=0,001.  La  comparación  entre  pacientes  con  SII  con  estren˜imiento
(IBS-C) en  ambos  grupos,  también  mostró  una  diferencia  estadísticamente  signiﬁcativa:  7,5
(6,0-8,5) vs  5,8  (3,5-7,2),  p=0,0051.
Conclusiones: Aquellos  pacientes  con  bajo  nivel  de  hidrógeno  respiratorio  excretado,  luego  de
la ingesta  de  lactulosa  presentaron  signiﬁcativamente  mayor  severidad  de  la  distensión  abdo-
minal, en  comparación  con  aquellos  con  un  alto  nivel  de  excreción  respiratoria  de  hidrógeno.
© 2011  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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rritable  bowel  syndrome  (IBS)  is  a  functional  bowel  disor-
er  characterized  by  the  association  of  abdominal  pain  or
iscomfort  with  an  alteration  in  bowel  habit.1 Its  exact  eti-
logy  remains  unknown;  it  is  thought  to  be  a  multifactorial
roblem,  and  may  include  altered  motility,  visceral  hyper-
ensitivity,  and  a  chronic  inﬂammatory  response.2 There  is
rowing  evidence  that  bacteria  may  play  a  role  in  IBS.3 It  is
lso  known  that  the  relative  predominance  of  speciﬁc  bacte-
ial  populations  may  determine  the  presenting  symptoms.4
Abdominal  bloating  is  a  common  symptom  among  these
atients,  and  its  exact  mechanism  is  unknown;  evidence  as
o  its  origin  points  toward  a  complex  interaction  of  multiple
actors,  such  as  intestinal  dysmotility  or  paradoxical  abdom-
nal  wall  movements,  as  contributors.5,6 This  could  be  the
esult  of  an  increased  production  of  intestinal  gas  and  is
elated  to  an  altered  fermentative  proﬁle.7--9 However,  it
s  not  known  whether  the  frequency  and  severity  of  abdom-
nal  bloating  ﬂuctuates  with  the  variations  in  pulmonary
ydrogen  excretion.  Our  aim  was  to  determine  the  differ-
nce  in  abdominal  bloating  severity  between  IBS  patients
ith  both  high  and  low  breath  hydrogen  excretion.
Since  low  breath  hydrogen  excretion  is  possibly  relatedo  an  increase  in  methane  excretion,  we  hypothesized  that
 difference  in  the  severity  of  abdominal  bloating  could  be
ound  due  to  the  effect  of  methane  on  intestinal  motility,  as
as  been  previously  described.10
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0ethods
 sequential  analysis  of  lactulose  breath  tests  (LBT)  car-
ied  out  at  the  Gastroenterology  Division  of  the  Centro
e  Educación  Médica  e  Investigación  Clínica  (CEMIC)  in
uenos  Aires-Argentina  between  July  2009  and  August  2010
as  performed.  Consecutive  outpatients  from  the  Gas-
roenterology  Division  with  a  diagnosis  of  IBS  according
o  Rome  III  criteria  were  selected.  Demographic  data  and
he  IBS  Severity  Symptom  Scale  (IBS-SSS)  scores  were  col-
ected.  The  bloating  score  was  compared  between  the
roups.
BS  Severity  Symptom  Scale
ll  patients  ﬁlled  out  the  IBS-SSS  questionnaire  to  assess
he  severity  of  their  symptoms.  This  scale  had  been  previ-
usly  translated  and  validated  into  Spanish11,12 and  consists
f  ﬁve  10-point  visual  analog  scales  to  rate  each  item.
he  items  evaluated  by  this  questionnaire  were:  abdom-
nal  pain  intensity,  abdominal  pain  frequency  (number  of
ays  over  the  last  ten  days  when  abdominal  pain  was
igniﬁcantly  present),  abdominal  bloating  severity,  satisfac-
ion  with  bowel  movement  frequency,  and  the  impact  of
ymptoms  on  patient  quality  of  life.  Abdominal  bloating
everity  was  calculated  in  each  patient  using  a  scale  from
 to  10.
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Figure  1  Images  corresponding  to  excreted  hydrogen  concen-
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Itration curves  x  time  with  high  area  under  the  curve.
PPM: parts  per  million;  AUC:  area  under  the  curve.
AUC  =  8064.
Lactulose  Breath  Test
The  LBT  was  performed  according  to  previously  described
techniques13 as  part  of  the  study  protocol  carried  out  on
these  patients  at  our  institution.  After  a  12-hour  fasting
period,  patients  were  asked  to  drink  10  g  of  lactulose  and
to  periodically  collect  exhaled  samples  of  breath  (every
20  minutes  for  a  three  hour  period).  The  samples  were  then
analyzed  for  hydrogen  concentrations  (measured  in  parts
per  million)  using  a  QuinTron® 12I  plus  gas  chromatograph
(QuinTron® Instruments  Company,  Milwaukee,  WI,  USA).  The
results  were  used  to  create  a  hydrogen  concentration/time
curve,  and  the  area  under  the  curve  (AUC)  was  calculated
for  each  case,  as  previously  done  by  Kotler  et  al.14
Patients  were  classiﬁed  into  two  groups  according  to  the
results  of  the  LBT:  those  with  a  low  (<1.000)  and  those  with
an  elevated  (>3.000)  AUC  (Figs.  1  and  2).  Those  patients
with  AUC  values  between  1.000  and  3.000  were  excluded,
because  these  values  are  considered  to  be  within  normal
range.
Patients  taking  part  in  the  trial  were  required  to  pay  for
their  lactulose  breath  tests.  This  expense  was  covered  by  the
health  insurance  of  those  subjects  that  could  not  afford
the  tests.  All  participating  patients  signed  an  informed  con-
sent  document  approved  by  the  Institutional  Review  Board
(IRB).
Statistical  Analysis
For  statistical  analysis,  Epi  Info® (3.5.1  Version,  Center  for
Disease  Control  and  Prevention,  Atlanta  GA)  was  used.  Cate-
gorical  variables  were  expressed  as  percentages.  Continuous
variables  were  expressed  as  mean  ±  standard  deviation
(SD),  or  median  with  interquartile  range,  in  the  case  of
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Figure  2  Images  corresponding  to  excreted  hydrogen  concen-
tration curves  x  time  with  low  area  under  the  curve.
PPM: parts  per  million;  AUC:  area  under  the  curve.
AUC  =  432.
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on-parametric  variables.  Comparison  of  continuous  varia-
les  was  made  using  the  Student’s  t  test  or  Mann-Whitney  U
est  for  non-parametric  variables.  Comparison  of  categorical
ariables  was  carried  out  using  the  Fisher’s exact  test.  A  p
alue  of  <0,05  was  considered  to  be  statistically  signiﬁcant.
esults
 total  of  380  patients  were  included  in  the  study.  One  hun-
red  and  twenty  patients  with  a  LBT  AUC  between  1.000
nd  3.000  were  excluded,  along  with  10  patients  unwilling
o  complete  the  IBS-SSS  questionnaire.  Sixteen  unsubtyped
BS  (IBS-U)  patients  were  also  excluded  because  of  the  small
umber  of  patients  in  this  group.  Two  hundred  and  thirty-
our  patients  were  classiﬁed  into  the  above-mentioned
roups:  190  in  the  AUC  >3.000  group  and  44  in  the  AUC
1.000  group.  The  baseline  characteristics  of  both  groups
re  shown  in  Table  1.  Forty-four  patients  (19%)  showed  an
arly  increase  in  hydrogen  excretion  compatible  with  small
ntestine  bacterial  overgrowth  (SIBO),  according  to  previ-
usly  used  criteria.12 These  patients  were  included  in  the
UC  >3.000  group.
There  was  a  signiﬁcantly  higher  proportion  of  IBS-C
atients  in  the  low  AUC  group,  and  a  higher  proportion  of
BS  with  diarrhea  (IBS-D)  in  the  high  AUC  group.  There  was
o  difference  in  age  or  sex  between  groups.
Severity  of  abdominal  bloating  was  compared,  as  shown
n  Table  2.  Patients  with  a  low  AUC  presented  a  slightly
igher,  but  signiﬁcant  score  in  abdominal  bloating  severity.
ince  abdominal  bloating  severity  has  been  associated  with
he  presence  of  constipation,  and  the  low  AUC  group  had
 higher  proportion  of  IBS-C  patients,  abdominal  bloating
cores  between  IBS-C  patients  in  both  groups  were  com-
ared.  Moreover,  the  difference  between  IBS-C  patients  in
oth  groups  remained  signiﬁcant.  Table  2  also  shows  the  dif-
erence  in  bloating  severity  between  IBS-D  and  mixed  IBS
IBS-M)  patients.
iscussion
n  the  current  study  we  found  that  those  IBS  patients  with
ow  hydrogen  excretion  in  the  LBT  have  slightly  higher,  but
igniﬁcant  abdominal  bloating  severity  than  those  with  ele-
ated  hydrogen  excretion,  a  ﬁnding  that  could  be  related  to
he  predominance  of  hydrogen-consuming  gut  ﬂora.
As  mentioned  before,  a  large  proportion  of  IBS  patients
omplain  of  abdominal  bloating,  irrespective  of  the  pre-
ominant  cathartic  symptom  pattern.5 There  are  several
actors  that  contribute  to  the  occurrence  of  bloating  in  these
atients,  and  probably  the  best  explanation  for  this  symp-
om  is  an  interaction  between  all  of  them.  For  instance,
remolaterra  et  al.  showed  that  the  inability  of  the  abdom-
nal  wall  muscles  to  adapt  to  the  changes  of  intraabdominal
olumes  is  related  to  this  symptom.6 It  could  be  associ-
ted  with  an  abnormal  production  of  intestinal  gas.  Accarino
t  al.  found  an  increase  in  intestinal  gas  production  during
loating  episodes  both  in  patients  with  intestinal  dysmotil-
ty  and  in  those  with  normal  function.  They  also  described
hanges  in  abdominal  wall  motion  during  these  episodes.15
There  is  considerable  evidence  demonstrating  that  bac-
erial  ﬂora  have  an  etiologic  role  in  the  genesis  of  IBS
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Table  1  Demographic  comparison  between  patients  with  abnormally  high  and  low  AUC  in  the  LBT.
Characteristic  Low  AUC  High  AUC  p  Value
n=44 n=190
Sex  (F/M)  (%)  34  (77,27)/10  (22,73)  137  (72,25)/53  (27,74)  0,340
Agea 55,34  ±  17,15  (22-79)  51,24  ±  16,65  (20-81)  0,140
Predominant  IBS  pattern
IBS-C  (%)  54,50  37  0,039
IBS-D (%)  11,36  26  0,044
IBS-M (%)  34,14  37  0,860
AUC: area under the curve; LBT: Lactulose Breath Test; IBS-C: irritable bowel syndrome with constipation; IBS-D: irritable bowel syndrome
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Fwith diarrhea; IBS-M: mixed irritable bowel syndrome.
a Values expressed as mean with standard deviation and range.
ymptoms.  Kassinen  et  al.  showed  that  the  fecal  micro-
iota  is  signiﬁcantly  altered  in  IBS  patients.16 Several  studies
how  an  increased  hydrogen  excretion  in  breath  tests  using
on-absorbable  saccharides,  suggesting  the  presence  of
IBO  in  IBS  patients.17,18 A  recent  meta-analysis  by  Shah
t  al.  described  a  LBT  sensitivity  and  speciﬁcity  of  43,6%
nd  83,6%,  respectively,  in  the  diagnosis  of  IBS.3 This  is
 very  controversial  point,  because  the  LBT  has  not  been
hown  to  be  a  useful  tool  for  distinguishing  IBS  patients
rom  controls.19 This  etiologic  association  is  further  sug-
ested  by  controlled  trials  that  have  shown  a  symptomatic
mprovement  in  IBS  patients  treated  with  antibiotics,  such
s  neomycin,  metronidazole  or  rifaximin.20--22
According  to  current  evidence,  patients  with  elevated
ydrogen  excretion  in  a  LBT  suffer  from  more  severe  and
requent  symptoms  than  those  that  have  a  normal-range  pul-
onary  excretion  of  this  gas.  However,  there  is  a  distinct
opulation  with  a  low  concentration  of  hydrogen  excretion
hat  may  have  a  different  symptomatic  pattern.  Extremely
ow  values  of  breath  hydrogen  have  been  shown  to  be
ssociated  with  methane  that  is  produced  by  intestinal
icroorganisms.  Cloarec  et  al.23 have  found  an  inverse  rela-
ionship  between  hydrogen  and  methane  concentrations  in
reath  tests  performed  on  normal  subjects.
We  excluded  those  patients  with  an  AUC  in  the  LBT
etween  1.000-3.000,  because  these  patients  have  values  of
ydrogen  excretion  considered  to  be  within  normal  limits,
ccording  to  previous  evidence.17
Hydrogen  measurement  in  the  LBT  shows  clear  advan-
ages  over  breath  methane  testing;  ﬁrst,  it  is  easier  to
t
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Table  2  Comparison  of  the  IBS-Severity  Symptom  Scale  and  the  L
Characteristic  Low  AUC  
AUCa 595  (445,5--800)  
Abdominal Bloating  7  (5,7--8)  
Score (ABS)a
ABS  in  IBS-Ca 7,5  (6--8,5)  
ABS in  IBS-Da 8  (0--9)  
ABS in  IBS-Ma 6,5  (3,5--7,75)  
LBT: Lactulose Breath Test; AUC: area under the curve; ABS: abdominal 
IBS-D: irritable bowel syndrome with diarrhea; IBS-M: mixed irritable b
a Values expressed as median and interquartile range.easure  and  therefore  is  more  feasible.24 On  the  other
and,  we  believe  the  hydrogen  breath  test  would  be  a  valu-
ble  initial  approach  in  selected  patients,  because  not  only
ould  its  low  excretion  be  inversely  related  to  methane
roduction,  but  it  could  also  reﬂect  the  predominance
f  sulphate-reducing  bacteria,  whose  inﬂuence  in  colonic
otor  abnormalities  is  not  known.  There  is  evidence  to  sup-
ort  the  idea  that  intestinal  gases,  such  as  methane,  can
e  active  molecules,  producing  an  alteration  in  intestinal
otor  function.  A  study  by  Pimentel  et  al.  showed  an  inverse
elationship  between  serotonin  concentration  and  methane
roduction  in  IBS  patients;  serotonin  is  known  to  partici-
ate  in  the  control  of  peristaltic  movements.  In  part,  this
ay  be  an  action  mechanism  of  methane  in  bowel  move-
ent  dysfunction.10 Furthermore,  the  abovementioned  can
xplain  why  patients  with  a  low  AUC  in  our  cohort  showed  a
igniﬁcantly  higher  frequency  of  IBS-C.  Agrawal  et  al.  found
 signiﬁcant  association  between  abdominal  distention  and
elayed  intestinal  transit  and  constipation.25 Intestinal  tran-
it  was  measured  by  the  LBT.  In  order  to  avoid  bias,  and  given
hat  IBS-C  patients  were  present  in  both  studied  groups,
hese  patients  were  analyzed  separately,  and  a signiﬁcant
ifference  was  still  found  in  the  abdominal  bloating  severity
core  between  high  and  low  AUC  in  the  LBT.
Study  limitations  have  been  taken  into  consideration.
irst  of  all,  we  did  not  measure  pulmonary  methane  excre-
ion.  Evidence  points  toward  a  link  between  methane
roduction  and  constipation,  and  could  be  related  to  the
ow  pulmonary  hydrogen  excretion  and  abdominal  bloat-
ng  severity  in  these  patients.  On  the  other  hand,  we  did
BT  between  groups.
High  AUC  p  Value
3.870  (3.000--6.752)  <0,001
6,5  (5--7,5)  <0,001
5,8  (3,5--7,2)  0,005
5,1  (0-6)  0,040
6  (0--7,5)  0,100
bloating score; IBS-C: irritable bowel syndrome with constipation;
owel syndrome.
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2Comparison  of  abdominal  bloating  severity  between  irritabl
not  take  into  account  some  relevant  clinical  variables  of
the  included  patients,  such  as  body  mass  index.  We  only
compared  abdominal  bloating  severity  between  groups,  and
did  not  consider  the  presence  and  severity  of  abdominal
distention.  Unfortunately,  breath  testing  is  an  indirect  and
imperfect  measurement  of  the  pathologic  action  of  gut  ﬂora.
However,  it  is  far  more  feasible  than  other  tests  that  are
considered  more  speciﬁc,  such  as  small  bowel  culture.  As  a
consequence,  care  must  be  taken  when  drawing  conclusions
from  the  results  of  our  study.
Conclusions
Patients  with  a  low  area  under  the  curve  in  the  lactulose
breath  test  have  more  severe  abdominal  bloating  than  the
IBS  patients  with  elevated  hydrogen  pulmonary  excretion,
regardless  of  the  predominant  clinical  pattern.
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